Vistin Pharma ASA (OSTO:VISTINo)
kr 24 0 (0%) Market Cap: 1.09 Bil Enterprise Value: 1.09 Bil PE Ratio: 18.53 PB Ratio: 3.64 GF Score: 50/100

Q3 2022 Vistin Pharma ASA Earnings Call Transcript

Oct 26, 2022 / 06:30AM GMT
Release Date Price: kr20.35
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Vistin Pharma Quarterly Report Q3 2022. (Operator Instructions). I would now like to turn the conference over to the CEO, Kjell-Erik Nordby. Please go ahead.

Kjell;Erik Nordby;Leave of Absence
Vistin Pharma ASA - CEO

()

Thank you very much. Welcome to Q3 conference call in Vistin Pharma. The call -- the presentation will be given by myself, Kjell-Erik Nordby, the CEO of the company; and Alexander Karlsen, the CFO.

To start with, we are happy to present to you the new company logo and the new company design, which was launched this month. You're also invited to our new website. And we believe that the new website and new design reflects a more modern version of Vistin Pharma and who we are at the moment.

So then continue to the highlights for the quarter. We had an all-time revenue in the quarter. The quarter ended at NOK 92 million versus NOK 63 million in the same quarter last year. This is up 46% in -- increase in revenue. This is a combination

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot